COVID-19 Pandemic Highlights Advantages of Digital Technology in Clinical Research

As the COVID-19 pandemic has disrupted many routine medical services and discretionary surgical procedures, little attention has been paid to its impact on clinical research. Many clinical trials and other medical research activities came to a sudden halt in March when the World Health Organization declared COVID-19 to be a pandemic. 

Regents Professor John C. Licciardone is a board-certified physician in Public Health and Preventive Medicine and Director of the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION) at the University of North Texas Health Science Center. He discusses how the PRECISION Pain Research Registry has maintained ongoing clinical research operations during the COVID-19 pandemic, including performance of its OPTIQUAL Trial. 

What is the PRECISION Pain Research Registry? 

PRECISION is a national registry that enrolls and studies participants with chronic low back pain. Its research emphasizes the biopsychosocial aspects of chronic pain and studies precision medicine to help improve health-related quality of life. The initial stages of development occurred from 2016 to 2018, when registry infrastructure and staffing focused on conducting quarterly in-person research visits in the Dallas-Fort Worth metroplex. However, as a member of the Work Group that developed the Federal Pain Research Strategy, it became evident that a national registry was a top priority in advancing the field of pain research. PRECISION adopted a digital technology platform in 2019, thereby facilitating its transition to a national pain research registry. 

Why has PRECISION been able to operate during the COVID-19 pandemic? 

The digital technology platform is used to manage all aspects of the research process when prospective participants approach the registry in response to national recruitment efforts via social media. Prospective participants complete a brief online survey and eligible participants are then invited to enroll by completing an online informed consent document. After giving consent, participants receive a hyperlink to complete the baseline research forms and receive a saliva collection kit via courier service for subsequent genetic analysis. Participant compensation is then provided using a debit card system and subsequent quarterly research encounters are scheduled electronically. These research processes have not been impacted by the COVID-19 pandemic. 

Has registry enrollment declined during the COVID-19 pandemic? 

No, the enrollment rate has actually increased during the pandemic, and is now approaching 1000 registry participants. In part, this is because the geographic reach of the registry was recently expanded from Texas to the contiguous 48 states and District of Columbia. However, the research team thought that some people may have more free time during the pandemic shutdowns to participate in the research registry. The research team is also beginning to assemble an affiliated national control panel of participants without chronic pain to enhance its research capabilities. 

How do you conduct a clinical trial during the COVID-19 pandemic? 

The ongoing randomized controlled trial, entitled “Optimizing Chronic Pain Management through Patient Engagement with Quality-of-Life Measures” exemplifies how this registry can be used to conduct clinical research during the COVID-19 pandemic. The intervention in this trial involves an educational tool that is immediately sent electronically to the experimental group and then later to the control group following completion of the trial. The intervention, study outcomes, and all other research data are based on “patient-reported” measures that do not require in-person research encounters. Such patient-reported measures are commonly used in pain research and other fields. 

More information about the PRECISION Pain Research Registry may be found at 

Filters close

Showing results

110 of 2528
Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

access_time Embargo lifts in 2 days
Embargo will expire: 12-Jul-2020 7:00 PM EDT Released to reporters: 10-Jul-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jul-2020 7:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jul-2020 9:00 AM EDT
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression
University of Texas Health Science Center at Houston

A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at UTHealth.

Showing results

110 of 2528